The company got approval to sell its tirzepatide injections—branded as Mounjaro—in a device called Kwikpen. Mounjaro is designed for long-term weight management and the treatment of type 2 ...
Novo Nordisk and Eli Lilly are racing to increase production in a weight-loss market estimated to reach at least $100 billion globally by the end of the decade. Both companies' obesity treatments ...